30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Meckler Jeffrey A

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Meckler Jeffrey A's trades of Travere Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-04
PlS Planned sale
90,012 -34.4%
123.79
US$1,282,593 		90,012 -34.4% 123.79 US$1,282,593
2026-05-04 2026-05-04
PrS Proposed sale
44,937
466.25
US$4,077,386 		44,937 466.25 US$4,077,386
2024-09-30 2024-09-30
PlS Planned sale
13,238 -0.7%
288.78
US$3,376,996 		13,238 -0.7% 288.78 US$3,376,996
2022-11-22 2022-11-21
B Purchase
9,600 +14.6%
1.90
US$18,240 		9,600 +14.6% 1.90 US$18,240
2022-11-22 2022-11-18
B Purchase
400 +0.6%
1.76
US$705 		400 +0.6% 1.76 US$705
2022-09-12 2022-09-08
B Purchase
10,308 +18.7%
2.80
US$28,862 		10,308 +18.7% 2.80 US$28,862
2022-09-08 2022-09-07
B Purchase
8,632 +18.6%
2.57
US$22,184 		8,632 +18.6% 2.57 US$22,184
2022-09-08 2022-09-06
B Purchase
1,060 +2.3%
2.44
US$2,586 		1,060 +2.3% 2.44 US$2,586
2022-06-07 2022-06-06
B Purchase
19,727 +76.9%
2.63
US$51,882 		19,727 +76.9% 2.63 US$51,882
2021-11-19 2021-11-18
B Purchase
11,187 +77.4%
5.82
US$65,108 		11,187 +77.4% 5.82 US$65,108